Andrew Seth Sandler - Apr 7, 2022 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
Director
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
Stock symbol
DRMA
Transactions as of
Apr 7, 2022
Transactions value $
$0
Form type
4
Date filed
4/8/2022, 07:15 PM
Previous filing
Jan 5, 2022
Next filing
Jul 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRMA Common Stock, par value $0.0001 per share Award $0 +5.19K $0.00 5.19K Apr 7, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 7, 2022, the Reporting Person was granted 5,190 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.